Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels

Fluidigm has announced new line of high-parameter Maxpar mass cytometry panels for immuno-oncology. Designed for use with the firm's Helios and CyTOF systems, the panels enable researchers to profile T cell subpopulations across 34 markers to identify all major T cell subsets, measure checkpoint molecule expression, identify activation states, and determine homing status. Provided as a modular panel system, researchers can combine the panels for complete coverage and customize individual panel sets with additional markers.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.